Brooklyn ImmunoTherapeutics to Present at the Access to Giving Virtual Investor Conference on July 15, 2021
12. Juli 2021 08:15 ET
|
Brooklyn Immunotherapeutics LLC
NEW YORK, July 12, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) (“Brooklyn” or “the Company”), a biopharmaceutical company focused on exploring the role that...
Brooklyn ImmunoTherapeutics Reports Inducement Grants
06. Juli 2021 17:57 ET
|
Brooklyn Immunotherapeutics LLC
NEW YORK, July 06, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) (“Brooklyn” or “the Company”), a biopharmaceutical company focused on exploring the role that...
Brooklyn ImmunoTherapeutics Executes Letter of Intent to Acquire Novellus Therapeutics
14. Juni 2021 07:30 ET
|
Brooklyn Immunotherapeutics LLC
NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene...
Brooklyn ImmunoTherapeutics Set to Join Russell 3000 Index
09. Juni 2021 07:30 ET
|
Brooklyn Immunotherapeutics LLC
BROOKLYN, N.Y., June 09, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and...